Walleye Trading’s CONMED CNMD Stock Holding History

Walleye Trading’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,800	Closed	-$182K	–	5111
2023 Q3	$182K	Buy	+1,800	New	+$207K	﹤0.01%	3665

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Walleye Trading's CNMD Position: Q1 2025 in Review

Walleye Trading sold out of CONMED (CNMD) in Q1 2025, closing a stake of 11,062 shares — an estimated $757K sold.

Walleye Trading first reported a position in CNMD in Q2 2015 and held it in 5 quarters. The position peaked at $961K in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

Walleye Trading reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
Walleye Trading sold 11,062 CONMED shares in Q1 2025, an estimated $757K.
Walleye Trading first reported a position in CONMED in Q2 2015 and held it in 5 quarters.
Walleye Trading's CONMED position peaked at $961K in Q3 2024.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.